Assembly Biosciences (ASMB) Misses Q2 EPS by 133c
Assembly Biosciences (NASDAQ: ASMB) reported Q2 EPS of ($1.33). Revenue for the quarter came in at $9.62 million.
For earnings history and earnings-related data on Assembly Biosciences (ASMB) click here.
